FDA Inspection
Tayca CorporationTayca Corporation – FDA Inspection, Aug 25, 2023
Record Details
This FDA Inspection record concerns Tayca Corporation, with an inspection on August 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6cd9ce85-bb7f-4a1a-9855-15ddab3b11ee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1219130
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Tayca Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tayca Corporation
- FDA Inspection 1038594 - 2017-12-15
- FDA Inspection 989845 - 2016-09-09
- FDA Inspection 855688 - 2013-11-08
- FDA Inspection 615187 - 2009-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.